Trupanion (NASDAQ:TRUP) Stock: Insider John Gallagher Sells 431 Shares

Trupanion, Inc. (NASDAQ:TRUP) COO John Gallagher sold 431 shares of Trupanion stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $29.12, for a total value of $12,550.72. Following the completion of the sale, the chief operating officer owned 32,880 shares in the company, valued at approximately $957,465.60. This trade represents a 1.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Trupanion Trading Down 0.2%

Shares of TRUP stock opened at $30.13 on Friday. The business’s fifty day moving average price is $26.89 and its 200 day moving average price is $26.69. The firm has a market capitalization of $1.32 billion, a PE ratio of 56.85, a P/E/G ratio of 1.80 and a beta of 1.44. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. Trupanion, Inc. has a 1-year low of $21.16 and a 1-year high of $46.98.

Trupanion (NASDAQ:TRUP) last released its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%. The company had revenue of $392.93 million during the quarter, compared to the consensus estimate of $389.72 million. During the same quarter last year, the company earned $0.22 earnings per share. Trupanion’s quarterly revenue was up 11.1% compared to the same quarter last year. As a group, sell-side analysts forecast that Trupanion, Inc. will post 0.63 EPS for the current fiscal year.

Hedge Funds Weigh In On Trupanion

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Bank of New York Mellon Corp purchased a new stake in Trupanion during the 2nd quarter worth about $4,631,000. Bank of America Corp DE purchased a new position in Trupanion during the second quarter worth approximately $14,262,000. Renaissancere Holdings Ltd. purchased a new position in Trupanion during the second quarter worth approximately $6,514,510. Legal & General Group Plc acquired a new position in shares of Trupanion in the 2nd quarter valued at $1,938,000. Finally, GSA Capital Partners LLP acquired a new position in shares of Trupanion in the 2nd quarter valued at $1,394,000.

Wall Street Analysts Forecast Growth

TRUP has been the subject of a number of research analyst reports. Atlantic Securities set a $42.00 price target on shares of Trupanion in a report on Wednesday, July 15th. Cantor Fitzgerald decreased their price objective on shares of Trupanion from $34.00 to $30.00 and set a “neutral” rating on the stock in a report on Wednesday, October 7th. Zacks Research lowered shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 24th. Piper Sandler lowered shares of Trupanion from an “overweight” rating to a “neutral” rating and lowered their target price for the stock from $45.00 to $32.00 in a research report on Wednesday, August 26th. Finally, Stifel Nicolaus increased their target price on shares of Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a report on Thursday, August 20th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $38.40.

Trupanion Company Profile

Trupanion, Inc is a pet insurance company that provides medical insurance coverage for cats and dogs. Its products are designed to help pet owners manage the cost of veterinary care, including coverage for eligible illnesses, injuries and other qualifying medical conditions, subject to the terms of each policy.

The company offers subscription-based pet insurance through the Trupanion brand, with coverage generally intended for ongoing veterinary expenses rather than routine or preventive care.